Risks, Safety Concerns, and Limitations Despite the potential benefits, using GLP-1 agents as adjunct therapy in type 1 diabetes is not without risks
BPC-157 $109.99 20mg You May Also Like Compound Information Technical specifications Stability Information Lyophilized (powder) -20C 24+ months Reconstituted 2-8C ~30 days Sources & References Peer-reviewed research PUBCHEM DATABASE BPC-157 compound identifiers, molecular data, and synonyms View Source PUBMED BPC-157 peer-reviewed literature search View Source PUBMED REVIEWS BPC-157 review articles and mechanistic overviews View Source PUBMED CENTRAL BPC-157 open-access research articles View Source EUROPE PMC BPC-157 expanded biomedical citation index View Source PUBMED METHODS
Studies show that GLP-1 receptor agonists can: Lower blood pressure Reduce inflammation in arteries Decrease bad cholesterol (LDL) Protect against heart failure 3
You could also notice tiny specks or particulates floating in the liquid that weren't there before
It may help lower blood pressure as part of weight loss and metabolic improvement, but high blood pressure should still be managed with medical guidance
Unfortunately, this trial did not phenotype patients as T2 high or low, which might limit some of their conclusions for the future utility based on the correct patient population [96]